Format

Send to

Choose Destination
J Lipid Res. 2019 Apr;60(4):869-879. doi: 10.1194/jlr.M091322. Epub 2018 Dec 31.

An upstream enhancer regulates Gpihbp1 expression in a tissue-specific manner.

Author information

1
Departments of Medicine University of California, Los Angeles, Los Angeles, CA 90095.
2
Department of Pediatrics, Division of Neurology, Rady Children's Hospital, University of California, San Diego, San Diego, CA 92123.
3
Department of Cellular and Molecular Medicine, School of Medicine, University of California, San Diego, La Jolla, CA 92093.
4
University of Michigan Transgenic Animal Model Core, Department of Medicine, University of Michigan Medical School, Ann Arbor, MI 48109.
5
Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ 85721.
6
Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ 85721 sgyoung@mednet.ucla.edu lfong@mednet.ucla.edu cromanoski@email.arizona.edu.
7
Departments of Medicine University of California, Los Angeles, Los Angeles, CA 90095 sgyoung@mednet.ucla.edu lfong@mednet.ucla.edu cromanoski@email.arizona.edu.
8
Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095.

Abstract

Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1), the protein that shuttles LPL to the capillary lumen, is essential for plasma triglyceride metabolism. When GPIHBP1 is absent, LPL remains stranded within the interstitial spaces and plasma triglyceride hydrolysis is impaired, resulting in severe hypertriglyceridemia. While the functions of GPIHBP1 in intravascular lipolysis are reasonably well understood, no one has yet identified DNA sequences regulating GPIHBP1 expression. In the current studies, we identified an enhancer element located ∼3.6 kb upstream from exon 1 of mouse Gpihbp1. To examine the importance of the enhancer, we used CRISPR/Cas9 genome editing to create mice lacking the enhancer (Gpihbp1 Enh/Enh). Removing the enhancer reduced Gpihbp1 expression by >90% in the liver and by ∼50% in heart and brown adipose tissue. The reduced expression of GPIHBP1 was insufficient to prevent LPL from reaching the capillary lumen, and it did not lead to hypertriglyceridemia-even when mice were fed a high-fat diet. Compound heterozygotes (Gpihbp1 Enh/- mice) displayed further reductions in Gpihbp1 expression and exhibited partial mislocalization of LPL (increased amounts of LPL within the interstitial spaces of the heart), but the plasma triglyceride levels were not perturbed. The enhancer element that we identified represents the first insight into DNA sequences controlling Gpihbp1 expression.

KEYWORDS:

chylomicrons; endothelial cells; fatty acid metabolism; glycosylphosphatidylinositol-anchored high density lipoprotein–binding protein 1; lipids; lipolysis; triglycerides

PMID:
30598475
PMCID:
PMC6446700
[Available on 2020-04-01]
DOI:
10.1194/jlr.M091322

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center